A Commercial Anti-TIF1γ ELISA Is Superior to Line and Dot Blot and Should Be Considered as Part of Routine Myositis-Specific Antibody Testing

Research output: Contribution to journalArticlepeer-review

9 Citations (SciVal)
29 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A Commercial Anti-TIF1γ ELISA Is Superior to Line and Dot Blot and Should Be Considered as Part of Routine Myositis-Specific Antibody Testing'. Together they form a unique fingerprint.

Medicine & Life Sciences